medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Number 5

<< Back Next >>

Ann Hepatol 2013; 12 (5)

Acute liver failure in under two year-olds - are there markers of metabolic disease on admission?

Brett A, Pinto C, Carvalho L, Garcia P, Diogo L, Gonçalves I

Language: English
References: 22
Page: 791-796
PDF size: 106.63 Kb.


ABSTRACT

Introduction. The early establishment of an etiology for acute liver failure (ALF) in infants is essential for the start of adequate treatment in the shortest timeframe possible. Aim. To identify markers of inherited metabolic disease on admission in children under two years of age with ALF. Material and methods. A retrospective review of the medical records of all children (‹ 2 years old) with ALF admitted to the pediatric hepatology or intensive care units of a tertiary center over a twenty-three year period (January 1989 to December 2011) was done. Patients were divided into two groups: with (group A) or without (group B) a metabolic etiology. Clinical and laboratory parameters on admission were compared. Results. Twenty-three children met inclusion criteria. Twelve had ALF of metabolic origin (group A). The median age in this group was 2.25 (Q1-Q3: 0.63-4.65) months and in group B 8.0 (Q1-Q3: 1.5-15) months. History of failure to thrive and/or vomiting was more frequent in group A (p = 0.022). Age, gender, encephalopathy and left ventricular hypertrophy were similar in both groups (p = 0.147, p = 1.000, p = 0.637, p = 1.000, respectively). Laboratory tests on admission (plasma lactate, ammonia, cholesterol, phosphate, INR, glucose, bilirubin, ALT, base excess and the presence of reducing substances in urine) showed no statistically significant differences between groups. Conclusion. This study showed that although infants with inborn errors of metabolism showed a trend towards lower age at presentation, the only marker of inherited metabolic disease found on admission was history of vomiting and/or failure to thrive.


REFERENCES

  1. Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 1996; 16: 349-55.

  2. Dhawan A, Mieli-Vergani G. Acute liver failure in neonates. Early Hum Dev 2005; 81: 1005-10.

  3. Krogstad P, Martin MG. Evaluation of acute liver failure. Pediatr Infect Dis J 2003; 22: 831-2.

  4. Squires RH Jr. Acute liver failure in children. Semin Liver Dis 2008; 28: 153-66.

  5. Saenz MS, Van Hove J, Scharer G. Neonatal liver failure: a genetic and metabolic perspective. Curr Opin Pediatr 2010; 22: 241-5.

  6. Saudubray JM, Nassogne MC, de Lonlay P, Touati G. Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol 2002; 7: 3-15.

  7. Kelly DA, McKiernan PJ. Metabolic liver disease in the pediatric patient. Clin Liver Dis 1998; 2: 1-30.

  8. Nobre S, Grazina M, Silva F, Pinto C, Goncalves I, Diogo L. Neonatal liver failure due to deoxyguanosine kinase deficiency. BMJ Case Rep 2012; 2012.

  9. Dimmock DP, Dunn JK, Feigenbaum A, Rupar A, Horvath R, Freisinger P, Mousson de Camaret B, et al. Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency. Liver Transpl 2008; 14: 1480-5.

  10. Whitington PF, Alonso AE. Fulminant hepatitis and acute liver failure. In: Kelly DA (ed). Diseases of the Liver and Biliary System in Children. Oxford: Blackwell; 2003, p. 107-26.

  11. Durand P, Debray D, Mandel R, Baujard C, Branchereau S, Gauthier F, Jacquemin E, et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediat 2001; 139: 871-6.

  12. Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH, Pediatric Acute Liver Failure Study G. Characterization and outcomes of young infants with acute liver failure. J Pediat 2011; 159: 813-8 e1.

  13. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediat 2006; 148: 652-8.

  14. Dhawan A. Acute liver failure in children and adolescents. Clin Res Hepatol Gastroenterol 2012; 36: 278-83.

  15. Vohra P, Haller C, Emre S, Magid M, Holzman I, Ye MQ, Iofel E, et al. Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediat 2000; 136: 537-41.

  16. Whitington PF, Kelly S, Ekong UD. Neonatal hemochromatosis: fetal liver disease leading to liver failure in the fetus and newborn. Pediatr Transplant 2005; 9: 640-5.

  17. Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology 2007; 45: 1555-65.

  18. Dimmock DP, Zhang Q, Dionisi-Vici C, Carrozzo R, Shieh J, Tang LY, Truong C, et al. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 2008; 29: 330-1.

  19. Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics 1998; 102: e69.

  20. Clayton PT. Inborn errors presenting with liver dysfunction. Semin Neonatol 2002; 7: 49-63.

  21. Kreuder J, Kahler SG. Approach to the patient with cardiovascular disease. In: Hoffmann GF, Zschocke J, Nyhan WL (eds.). Inherited Metabolic Diseases: A Clinical Approach: Springer-Verlag Berlin Heidelberg; 2010, p. 69-88.

  22. Shanmugam NP, Bansal S, Greenough A, Verma A, Dhawan A. Neonatal liver failure: aetiologies and management—state of the art. Eur J Pediatr 2011; 170: 573-81.




2020     |     www.medigraphic.com